Collaborative Research Inc. announced Friday that it has beenawarded two Phase I small business innovation research (SBIR)grants to develop two different aspects of its large-scale,computer-assisted genome sequencing technology.

One award, worth $50,000, is from the National Center forHuman Genome Research. It is targeted for the development ofa general purpose sequence assembly algorithm andcorresponding software to address the bio-informaticsproblems associated with sequencing large sections of genomicDNA.

The second SBIR, for $75,000, came from the Department ofEnergy. That award is for the development of an extremelysensitive, non-radioactive binary detection system which willsignificantly increase the speed and reduce the cost of large-scale genome sequencing.

Both awards will supplement Collaborative's (NASDAQ:CRIC)efforts to complete the rapid, large-scale sequencing of theentire genome of Mycobacterium tuberculosis, the pathogenresponsible for tuberculosis. The information generated by theWaltham, Mass. company will be used to identify gene targetsfor therapeutics and vaccines.

(c) 1997 American Health Consultants. All rights reserved.